TOUCHLIGHT
LIVE

Serial Number

99041690

Owner

Touchlight IP Limited

Attorney

Rebecca Liebowitz

Filing Date

Feb 14, 2025

Add to watchlist:

No watchlists yet
View on USPTO

TOUCHLIGHT Trademark

Serial Number: 99041690 • Registration: 8148424

TOUCHLIGHT is a trademark filed by Touchlight IP Limited on February 14, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Touchlight IP Limited (15 trademarks)

Morelands And Riverdale Buildings

Entity Type: 99

Trademark Details

Filing Date

February 14, 2025

Registration Date

February 24, 2026

Published for Opposition

January 6, 2026

Goods & Services

Chemicals, enzymes, nucleic acid constructs and viral vectors for scientific and research use; nucleic acid constructs and viral vectors for use in the manufacture of nucleic acids; nucleic acid constructs and viral vectors for manufacturing viruses; nucleic acid constructs and viral vectors for use in scientific research, agribiotechnology, and nanotechnology; two-dimensional and three-dimensional nucleic acid constructs for creating nanostructures and scaffolds; all of the aforementioned goods not for medical or veterinary use

Scientific and technological services, namely, research and design in the fields of chemicals, enzymes, nucleic acid constructs, and viral vectors; chemical and biological analysis and research services; research into nucleic acids and nucleic acid constructs; research and development into the creation of nucleic acid constructs; research, analysis, design, and development relating to therapies, prophylactics, and counteragents based on nucleic acid constructs; research and development in the fields of gene therapy, diagnostic preparation, agribiotechnology, and nanotechnology; consultancy relating to the aforesaid services

Treatment of nucleic acid constructs; manufacture for others of nucleic acid constructs; manufacture for others of nucleic acids; manufacture for others of viruses; manufacture for others of vectors; manufacture for others of medical and veterinary therapies, vaccines, prophylactics, and counteragents; manufacture for others of nucleic acid constructs for nanotechnology applications; manufacture for others of nucleic acid constructs for labeling, imaging, and sensing applications; manufacture for others of nucleic acid constructs for electronic components; consultancy relating to the custom manufacture of the aforementioned goods

Nucleic acid constructs for medical and veterinary purposes; nucleic acid constructs and viral vectors for use as prophylactic or therapeutic vaccines; nucleic acid constructs and viral vectors for the production of prophylactic or therapeutic vaccines; nucleic acid constructs and viral vectors for medical use; nucleic acid constructs and viral vectors for the production of therapeutic or prophylactic viruses; nucleic acid constructs and viral vectors for gene therapy; nucleic acid constructs and viral vectors for use in cell therapy; nucleic acid constructs and viral vectors for use in genome editing; nucleic acid constructs and viral vectors for use in therapy

Apparatus and instruments for the manufacture and processing of nucleic acid constructs, namely, DNA amplification apparatus and instruments for scientific and research purposes; nucleic acid constructs comprising natural and unnatural nucleotides, namely, nucleic acid amplification apparatus for scientific purposes; nucleic acid constructs comprising synthetic backbones or a mixture of natural and synthetic backbones, namely, nucleic acid amplification apparatus for scientific purposes; composites of nucleic acid constructs with organic and inorganic chemicals, namely, nucleic acid amplification apparatus for scientific purposes; all the aforesaid goods for use in nanotechnology applications including data storage, data retrieval and computing; electronic components in the form of electrical wires, semi-conductors, transistors, rectifiers, diodes, light emitting diodes (LEDs), and systems for energy storage, namely, batteries, all containing nucleic acid constructs; apparatus that uses nucleic acid constructs for labeling, imaging, and sensing applications for scientific research purposes; nucleic acid constructs as smart materials, being components of devices used for labeling, imaging and sensing DNA sequences for scientific research purposes; replacement parts for all the aforesaid technology

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 24, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 24, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 6, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jan 6, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 31, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 8, 2025 CNSA
ATTORNEY REVIEW COMPLETED
Dec 8, 2025 ATRV
EXAMINER'S AMENDMENT ENTERED
Dec 8, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 8, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 8, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 8, 2025 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 21, 2025 GNFN
FINAL REFUSAL E-MAILED
Oct 21, 2025 GNFR
FINAL REFUSAL WRITTEN
Oct 21, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 20, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 20, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 20, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 29, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jul 29, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jul 29, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 22, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 9, 2025 NWOS
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 25, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Feb 25, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 25, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 25, 2025 REAP
APPLICATION FILING RECEIPT MAILED
Feb 14, 2025 MAFR
NEW APPLICATION ENTERED
Feb 14, 2025 NWAP